Increased Left Atrial Stiffness is Significantly Associated with Paroxysmal Atrial Fibrillation in Diabetic Patients
Diana-Aurora Arnautu,Sergiu-Florin Arnautu,Mirela-Cleopatra Tomescu,Silvia Luca,Constantin-Tudor Luca
DOI: https://doi.org/10.2147/DMSO.S417675
2023-07-12
Abstract:Diana-Aurora Arnautu, 1, 2 Sergiu-Florin Arnautu, 1, 3 Mirela-Cleopatra Tomescu, 1, 3 Silvia Luca, 2, 4 Constantin-Tudor Luca 2, 4 1 Multidisciplinary Heart Research Center of the "Victor Babes", Internal Medicine Department, University of Medicine and Pharmacy, Timisoara, Romania; 2 Institute of Cardiovascular Diseases, Timisoara, Romania; 3 Municipal Clinical Emergency Hospital, Timisoara, Romania; 4 Department of Cardiology, Victor Babes University of Medicine and Pharmacy, Institute of Cardiovascular Diseases, Timisoara, Romania Correspondence: Sergiu-Florin Arnautu, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania, Email Purpose: Atrial fibrillation (AF) and diabetes mellitus (DM) are common pathogenic diseases. Diabetes is an independent risk factor for AF, and coexisting AF is a risk factor for the diabetic pa-tient's progression. The purpose of this study was to see if two-dimensional-speckle tracking echocardiography (2D-STE) might provide valuable criteria for determining the risk of AF in diabetic patients. Patients and Methods: This retrospective study compared 30 adult diabetic patients with documented paroxysmal atrial fibrillation (PAF) with 30 age- and sex-matched diabetic patients without PAF. Inclusion criteria were: age ≥ 18 years, sinus rhythm, diabetes mellitus type 2, and the ability to sign the informed consent. Exclusion criteria included: moderate or severe valvular disease, previous myocardial infarction, left ventricular ejection fraction (LVEF) < 50%, congenital heart disease, a history of cardiac surgery, paced atrial or ventricular rhythm, inadequate echocardiography imaging. The medical history, clinical, biochemical data and the results of the transthoracic cardiac ultrasound examination were registered during their evaluation at the outpatients cardiology clinics. Results: The mean age of the patients was 62.5± 1.7 years, 60% were men. Diabetic patients who experienced PAF episodes demonstrated significantly impaired left atrial (LA) deformation patterns, with decreased LA strains and increased LA stiffness (p < 0.05). Conclusion: The present study demonstrates that LA strains and LA stiffness are significantly associated with the occurrence of PAF in diabetic patients. As 2D-STE of the LA is more sensitive than routine echocardiographic examination, it should be performed in patients suspected of being suffering from PAF. Keywords: diabetes mellitus, paroxysmal atrial fibrillation, 2D-speckle tracking echography, left atrial strains, left atrial stiffness With a current incidence of 2–4%, atrial fibrillation (AF) is the most prevalent persistent cardiac arrhythmia in people around the world. 1 It is expected that one in every three Europeans over the age of 55 will have this disorder. 2 AF patients have a 5-fold risk of having a stroke, a higher prevalence of heart failure, and a higher death rate. 3 AF is frequent in patients with type 2 diabetes, with a prevalence rate estimated to be at least twice compared to nondiabetic individuals. 4 Diabetes mellitus (DM) has been linked to an increased risk of cardiovascular disease and, when this condition is present, it doubles the chance of a fatal event. 5 Diabetes, independent of hypertension or diastolic function, is also associated with an increase in the size of the left atrium (LA); it also induces sympathetic and parasympathetic denervation of the latter. 1 AF prevalence is approximately three times greater in diabetic patients with hypertension, than in AF patients with either diabetes or hypertension. 6 There is disagreement over whether type 2 diabetes is an independent risk factor for AF. 4,7,8 Several studies, however, have found a link between type 2 diabetes and atrial fibrillation. 5,9 Furthermore, diabetes is one of the risk factors included in the CHA2DS2-VASc-score risk stratification scheme. 10 LA size is recognized to be a useful predictor of paroxysmal atrial fibrillation (PAF) in the general population as well as in patients with a variety of pathologies. 11,12 Atrial dilatation does not discriminate between valvular and non-valvular AF since it also occurs in left ventricular diastolic failure and arterial hypertension. Nevertheless, PAF has been found in individuals with normal LA dimensions. 13–15 Recent studies have shown that LA function parameters surpass LA size measurements as a predictor of PAF, particularly when investigating deformation anomalies using two-dimensional speckle-tracking echocardiography (2D-STE). 14–16 The -Abstract Truncated-
endocrinology & metabolism